This story has been updated to include additional comments from FYR Diagnostics.
NEW YORK – Ensuring adequate access to testing has been a key hurdle during the COVID-19 pandemic, with test and supply shortages causing roadblocks and capacity not being met.
But a new test in the works from Missoula, Montana-based FYR Diagnostics could be part of the solution.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.